Cytokinetics CYTK
NASDAQ CYTK
$62.58 -1.38 (-2.15%)
As of: Oct 21, 2026 · 3:14 PM EDT

Cytokinetics (CYTK) Tax Provisions (2010)

Updated

Cytokinetics' Tax Provisions came in at -$176,000 for FY2010, compared with $150,000 in FY2009.

Analysis

Cytokinetics (CYTK) Tax Provisions (2010) Analysis & Trends

  • Per Business Quant, earlier years put Tax Provisions at $150,000 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn 1.21 Bn
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn 662.00 Mn
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn 291.00 Mn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn 242.00 Mn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn -407.00 Mn
10 Cytokinetics 8.25 Bn 4.42 Bn 25.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 -176,000.00
API Access

Cytokinetics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=CYTK&period=max&api_key=YOUR_API_KEY